Penn Dental Study Shows Early Challenges to Immune System Disrupt Oral Health

Once viewed only as infectious invaders, bacteria are now understood to play an important role in overall health. After the gut, the mouth is the second most diverse human microbial system. However, it has been vastly overshadowed by the focus on the microbiome of the gut. https://mma.prnewswire.com/media/1474280/Penn_Dental_Medicine_Logo.jpg Now, a collaborative team including Modupe O. Coker

James River Church Announces Tiffany Hudson and Jenn Johnson of Bethel Worship as 2025 Designed for Life Conference Special Guests

James River Church and Designed for Life are proud to announce Jenn Johnson, Bethel Worship, and Grammy Award-winning Tiffany Hudson as special guests at the 2025 DFL Conference. James River Church is thrilled to announce Grammy Award-winning artist Tiffany Hudson of Elevation Worship and Jenn Johnson of Bethel Music as featured musical guests at the

PEPG Investors Have Opportunity to Lead PepGen Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstPepGen Inc. (“PepGen” or “the Company”) (NASDAQ: PEPG) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

VSTS Investors Have Opportunity to Lead Vestis Corporation Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstVestis Corporation (“Vestis” or “the Company”) (NYSE: VSTS) forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

Introducing 1 Hour Payday Loans Online from 1F Cash Advance! Experience Instant Approval Loans with No Credit Check and Get Your Quick Cash the Same Day You Apply

BOULDER, Colo., July 31, 2025 (GLOBE NEWSWIRE) — 1F Cash Advance, a responsive fintech committed to delivering fast, people-focused financial solutions, today announces the nationwide launch of its enhanced 1-Hour Payday Loan product. Designed to support Americans with bad credit facing unexpected expenses, the product offers quick financial relief. It addresses record-high financial stress levels

Wellness Starts from Within: Activia Gut Glow-Up Campaign Marks New, Modern Chapter with Launch of Activia Proactive Yogurt and Product Refresh

Activia's got you – and your glow-up – covered with tips, tools, and tasty gut health support — Activia launches the Gut Glow-Up campaign – a science-backed, modern movement designed to help people shine from the inside out, introducing thefirst-ever Gut Glow-Up Guru, Dr. Amy Shahto showcase the impact of putting your gut first –

Introducing 1 Hour Payday Loans Online from 1F Cash Advance! Experience Instant Approval Loans with No Credit Check and Get Your Quick Cash the Same Day You Apply

Introducing 1 Hour Payday Loans Online from 1F Cash Advance! Experience Instant Approval Loans with No Credit Check and Get Your Quick Cash the Same Day You Apply 1F Cash Advance introducing 1 Hour Payday Loans Online designed for urgent financial emergencies. Apply for No Denial Payday Loans today and Get Same-Day Loan with Guaranteed

PREMIUM Development Marks Milestone with Sale of FIFTEEN Apartments, a Boutique Luxury Community in Miami

PREMIUM Development Inc. has successfully completed the sale of its second U.S. project: FIFTEEN Apartments, a boutique, European-style luxury multifamily community located in Miami's Health District. The transaction was brokered by Walker & Dunlop, Inc. https://mma.prnewswire.com/media/2741921/Premium_Development_Inc.jpg Completed in 2024, FIFTEEN Apartments is a mid-rise luxury community offering thoughtfully designed residences with condominium-quality finishes and a

Immunophotonics Completes Treatment of Last Patient in INJECTABL-1 Phase 1b/2a Clinical Trial of IP-001 for Advanced Solid Tumors

IP-001, Immunophotonics' proprietary glycan polymer, is designed to transform tumor ablation into personalized systemic cancer immunotherapies Immunophotonics, Inc., a clinical-stage biotech company developing novel immunostimulatory drugs to improve efficacy of routine tumor destruction techniques, has announced the completion of treatment of the last patient in its INJECTABL-1 multicenter Phase 1b/2a clinical trial of IP-001 for

Scroll to Top